GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
Crossref DOI link: https://doi.org/10.1007/s13300-019-0642-2
Published Online: 2019-06-10
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rasalam, Roy http://orcid.org/0000-0002-6822-7936
Barlow, John
Kennedy, Mark
Phillips, Pat
Wright, Alan
Funding for this research was provided by:
Eli Lilly Australia
Article History
Received: 1 May 2019
First Online: 10 June 2019